GERALD COLVIN: Open Payments
NPI 1417954199 · WAKEFIELD, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,658 in 122 payments from 40 companies in 2025. Trend: 2023 $41,581 · 2024 $43,960 · 2025 $8,658
Consulting: $5,798Food & beverage: $2,753Education: $108
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $3,376 |
| Janssen Biotech, Inc. | 13 | $1,647 |
| Sandoz Inc. | 1 | $1,350 |
| Rigel Pharmaceuticals, Inc. | 10 | $339 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $143 |
| PFIZER INC. | 9 | $143 |
| Kite Pharma, Inc. | 1 | $122 |
| Inspire Medical Systems, Inc. | 5 | $117 |
| ABBVIE INC. | 4 | $116 |
| Merck Sharp & Dohme LLC | 4 | $84 |
Products named: ERLEADA, TAVALISSE, ELIQUIS, Yescarta, INSPIRE, DARZALEX, RYBREVANT, JAKAFI.
Industry payments across RI — which companies pay providers there.
